REPORT ID 6987

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2019

Publish Date
2019
Pages
129
Format
Electronic (PDF)

In this report, the EMEA Radiopharmaceuticals in Nuclear Medicine market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bracco Imaging S.P.A.
    Cambridge Isotope Laboratories, Inc.
    Cardinal Health, Inc.
    Covidien, Plc
    Eczacibasi-Monrol
    Fujifilm Holdings Corporation
    GE Healthcare (Subsidiary Of General Electric Company)
    IBA Group
    Isotec, Inc. (Sigma-Aldrich)
    Lantheus Medical Imaging, Inc.
    Nordion, Inc.
    Ntp Radioisotopes (Pty), Ltd.
    Siemens Healthcare (Subsidiary Of Siemens AG)
    Taiyo Nippon Sanso Corporation
    Urenco Limited
    Rotem Industries, Ltd., Inc.
    Australian Nuclear Association And Technology Organization (ANSTO)
    Board of Radiation And Isotope Technology (BRIT)
    Institute of Atomic Energy Polatom Radioisotope Centre
    Institute of Isotopes Co., Ltd.
    Institute Of Radioelement (IRE)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals
    Enriched Stable Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including
    Diagnostic Application
    Therapeutic Application
    Research
    Pharmaceutical
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market  Report 2019
1 Radiopharmaceuticals in Nuclear Medicine Overview
    1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
    1.2 Classification of Radiopharmaceuticals in Nuclear Medicine
        1.2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Diagnostic Radiopharmaceuticals
        1.2.4 Therapy Radiopharmaceuticals
        1.2.5 Enriched Stable Isotopes
    1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Market by Application/End Users
        1.3.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Diagnostic Application
        1.3.3 Therapeutic Application
        1.3.4 Research
        1.3.5 Pharmaceutical
        1.3.6 Other
    1.4 EMEA Radiopharmaceuticals in Nuclear Medicine Market by Region
        1.4.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medicine ( 2014-2024)
        1.5.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate ( 2014-2024)

2 EMEA Radiopharmaceuticals in Nuclear Medicine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Competition by Players/Manufacturers
        2.1.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price by Players ( 2014-2019)
    2.2 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price by Type ( 2014-2019)
    2.3 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume) by Application
    2.4 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Region
        2.4.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Price by Region ( 2014-2019)

3 Europe Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Value ( 2014-2019)
        3.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
    3.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
    3.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries ( 2014-2019)
        3.4.3 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        3.4.4 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)

4 Middle East Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Value ( 2014-2019)
        4.1.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
    4.3 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
    4.4 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Radiopharmaceuticals in Nuclear Medicine Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)

5 Africa Radiopharmaceuticals in Nuclear Medicine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Value ( 2014-2019)
        5.1.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
    5.3 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
    5.4 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate ( 2014-2019)

6 EMEA Radiopharmaceuticals in Nuclear Medicine Manufacturers/Players Profiles and Sales Data
    6.1 Bracco Imaging S.P.A.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Cambridge Isotope Laboratories, Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Cardinal Health, Inc.
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Covidien, Plc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Eczacibasi-Monrol
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Fujifilm Holdings Corporation
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 GE Healthcare (Subsidiary Of General Electric Company)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 IBA Group
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Isotec, Inc. (Sigma-Aldrich)
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Lantheus Medical Imaging, Inc.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Nordion, Inc.
    6.12 Ntp Radioisotopes (Pty), Ltd.
    6.13 Siemens Healthcare (Subsidiary Of Siemens AG)
    6.14 Taiyo Nippon Sanso Corporation
    6.15 Urenco Limited
    6.16 Rotem Industries, Ltd., Inc.
    6.17 Australian Nuclear Association And Technology Organization (ANSTO)
    6.18 Board of Radiation And Isotope Technology (BRIT)
    6.19 Institute of Atomic Energy Polatom Radioisotope Centre
    6.20 Institute of Isotopes Co., Ltd.
    6.21 Institute Of Radioelement (IRE)

7 Radiopharmaceuticals in Nuclear Medicine Manufacturing Cost Analysis
    7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Radiopharmaceuticals in Nuclear Medicine Market Forecast ( 2019-2025)
    11.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Forecas